Events by Type: Lectures and Panels
Pandemic Resilience: Testing
Event Description Danielle Allen, Ganesh Sitaraman, and E. Glen Weyl will discuss pandemic resilience and testing in this conversation on the Edmond J. Safra Center for Ethics' COVID-19 white paper…
Online ONLY Addressing the Public Health Crisis at Border Detention Centers: A Health Policy and Bioethics Consortium
Online Viewing In light of the rapidly developing COVID-19 outbreaks, Harvard University has restricted on-campus events. As a result, we will not be allowing in-person attendance at this event. Instead,…
Ethical Dilemmas in Mask and Equipment Shortages: Health Care During the COVID-19 Pandemic
Online Viewing Fully captioned video of the panel discussion and panelists' slide presentations below! Join the conversation on Twitter: @PetrieFlom #PPEethics! Event Description Personal protective equipment or PPE has been…
Video now available! Disability, COVID-19, and Triage: Exploring Resource Allocation and the Framing of Disability
Online Resources Couldn't join the webinar? Learn more about the issues. Check out some scholarship from our panelists. Check out the conversation @PetrieFlom using #disabilitycovidtriage! Watch fully captioned video…
Online ONLY Addiction: A Paradigm Shift from Problem to Patient through Policy: A Health Policy and Bioethics Consortium
Online Viewing In light of the rapidly developing COVID-19 outbreaks, Harvard University has restricted on-campus events. As a result, we will not be allowing in-person attendance at this event. Instead,…
Private Funding of Drug Discovery: Ethical Issues, Practical Alternatives: A Health Policy and Bioethics Consortium
Description The traditional model for drug development begins with publicly-funded science based in academic or government laboratories before private investors and for-profit pharmaceutical manufacturers become involved with their substantial expertise…
The Evolution of Hope in Advanced Illness: A Key to Health System Transformation
Description Despite most patients’ preferences to die at home among their loved ones, many with end-stage cancer, heart failure, and other advanced illnesses spend their last days in the…
The Next Frontier of Neuroscience and Juvenile Justice
Event Description In the fifteen years since the United States Supreme Court referred to developmental science in ruling the death penalty unconstitutional for juveniles in Roper v. Simmons, state and…
Video now available! Lessons from Germany on Controlling Prescription Costs
Description To control the costs of prescription drugs, Germany combines immediate access to innovative drugs with price controls. The system assesses scientific evidence on the value of new drugs to…
The ‘Nudgability’ Model for More Ethical Clinical Research
The concept of “nudging,” has been thoroughly discussed and debated in the context of health care, and particularly in the public health domain. The use of nudging in…
Video now available! Soda Taxes and Other Policy Responses to the American Obesity Epidemic: A Health Policy and Bioethics Consortium
Couldn't join us for the event? Check out the speakers' slide presentations! Description In recent years, some cities have tried to impose soda taxes and other new policies to…
Book Talk: When Misfortune Becomes Injustice: Evolving Human Rights Struggles for Health and Social Equality
Description When Misfortune Becomes Injustice (Stanford University Press, February 2020) surveys the progress and challenges faced in deploying human rights to advance health and social equality over the last thirty years,…
Gun Violence: The Health Care System’s Role in a Public Health Epidemic: A Health Policy and Bioethics Consortium
There is an epidemic of gun violence in the United States. Physicians are often on the frontline, but what can the health care system do to stem the epidemic? What…
Biomarkers in Cancer Drug Approvals: New Opportunities and Challenges: A Health Policy and Bioethics Consortium
The FDA recently approved Keytruda and Vitrakvi, two cancer drugs targeting biomarkers without reference to the site of the disease. Defining cancer in terms of biomarkers alone may require us…
Computational Justice: How Artificial Intelligence and Digital Phenotyping Can Advance Social Good
Couldn't join us for the event? Check out some of the panelists' slide presentations below! And read a write-up of the event in the Harvard Crimson! Description The future…
The Past and Future of Tobacco Regulation: A Health Policy and Bioethics Consortium
Description After decades of efforts to better regulate the sale of tobacco products, the U.S. has finally seen reductions in overall smoking levels. However, new dangers emerging from growing…
Data Privacy 3.0: Are We Ready for AI?
Description How can India take advantage of data to achieve its developmental objectives while balancing the need for personal privacy? The recently implemented Account Aggregator framework tries to establish a…
Book Launch: Transparency in Health and Health Care in the United States
Description In June 2019, Cambridge University Press published Transparency in Health and Health Care in the United States. This volume, edited by Holly Fernandez Lynch, I. Glenn Cohen, Carmel Shachar, and…
Playing Games in the Prescription Drug Market: Cost Implications and Legal Solutions: A Health Policy and Bioethics Consortium
Description There is substantial debate over whether and how we should screen the general population to detect cancers such as breast, prostate, and colon cancer. The principle of early detection…
2019 Petrie-Flom Center Open House
Description At this reception, we welcomed faculty, colleagues, and students with shared interests in health law policy, biotechnology, and bioethics, and discussed what the Petrie-Flom Center does and how to…